LSA
MRNA icon

Leonteq Securities AG’s Moderna MRNA Stock Holding History

Leonteq Securities AG’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Sell
267,131
-35,244
-12% -$1.82M 0.64% 35
2026
Q1 		$15.4M Sell
302,375
-33,291
-10% -$1.55M 0.57% 33
2025
Q4 		$9.9M Sell
335,666
-204,466
-38% -$5.55M 0.3% 60
2025
Q3 		$14M Buy
540,132
+6,801
+1% +$190K 0.42% 42
2025
Q2 		$14.7M Buy
533,331
+96,760
+22% +$2.55M 0.57% 33
2025
Q1 		$12.4M Buy
436,571
+251,223
+136% +$8.92M 0.7% 20
2024
Q4 		$7.71M Buy
185,348
+55,053
+42% +$2.63M 0.52% 33
2024
Q3 		$8.71M Buy
130,295
+123,674
+1,868% +$11.4M 0.66% 26
2024
Q2 		$786K Sell
6,621
-43,910
-87% -$5.56M 0.06% 240
2024
Q1 		$5.38M Sell
50,531
-95
-0.2% -$9.58K 0.4% 64
2023
Q4 		$5.03M Sell
50,626
-37,360
-42% -$3.14M 0.29% 77
2023
Q3 		$9.09M Sell
87,986
-26,112
-23% -$2.91M 0.5% 48
2023
Q2 		$13.9M Buy
114,098
+89,184
+358% +$11.9M 0.72% 35
2023
Q1 		$3.83M Sell
24,914
-79,567
-76% -$13.1M 0.17% 112
2022
Q4 		$18.8M Sell
104,481
-233,507
-69% -$38.2M 0.7% 26
2022
Q3 		$40M Buy
337,988
+35,981
+12% +$5.46M 1.55% 15
2022
Q2 		$43.1M Buy
302,007
+98,367
+48% +$14.1M 1.62% 12
2022
Q1 		$35.1M Buy
203,640
+70,696
+53% +$11.9M 1.25% 15
2021
Q4 		$33.8M Buy
132,944
+101,945
+329% +$29.8M 1.22% 18
2021
Q3 		$11.9M Buy
30,999
+7,883
+34% +$2.91M 0.51% 51
2021
Q2 		$5.43M Buy
23,116
+2,278
+11% +$407K 0.32% 64
2021
Q1 		$2.73M Buy
20,838
+7,698
+59% +$1.12M 0.16% 121
2020
Q4 		$1.37M Buy
+13,140
New +$1.33M 0.07% 216

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Leonteq Securities AG's MRNA Position: Q2 2026 in Review

Leonteq Securities AG reduced its Moderna (MRNA) stake by 12% in Q2 2026, selling an estimated $1.82M and leaving 267,131 shares worth $18.7M. The position accounts for 0.64% of the portfolio, ranked #35.

Leonteq Securities AG first reported a position in MRNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $43.1M in Q2 2022. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Leonteq Securities AG held 267,131 shares of Moderna worth $18.7M as of Q2 2026.
  • Leonteq Securities AG sold 35,244 Moderna shares in Q2 2026, an estimated $1.82M.
  • Moderna made up 0.64% of Leonteq Securities AG's portfolio in Q2 2026, its #35 holding.
  • Leonteq Securities AG first reported a position in Moderna in Q4 2020 and has held it in 23 quarters since.
  • Leonteq Securities AG's Moderna position peaked at $43.1M in Q2 2022.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.